Market Cap (In CNY)
14.49 Billion
Revenue (In CNY)
4.05 Billion
Net Income (In CNY)
284.39 Million
Avg. Volume
3.19 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 19.19-35.46
- PE
- -
- EPS
- -
- Beta Value
- 0.305
- ISIN
- CNE100001CJ0
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Shao Bo Li
- Employee Count
- -
- Website
- https://www.sinocare.com
- Ipo Date
- 2012-03-19
- Details
- Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.
More Stocks
-
605186
-
WINGWingstop Inc.
WING
-
PAKKAPakka Limited
PAKKA
-
MPVD
-
OBIO
-
MDPR
-
DIANATEADiana Tea Company Limited
DIANATEA
-
ZDGGFZOO Digital Group plc
ZDGGF